Suppr超能文献

在不增加I型错误率的情况下,在两样本实验的中期增加样本量。

Increasing the sample size at interim for a two-sample experiment without Type I error inflation.

作者信息

Dunnigan Keith, King Dennis W

机构信息

STATKING Consulting, Cincinnati, OH, USA.

出版信息

Pharm Stat. 2010 Oct-Dec;9(4):280-7. doi: 10.1002/pst.390.

Abstract

For the case of a one-sample experiment with known variance σ² =1, it has been shown that at interim analysis the sample size (SS) may be increased by any arbitrary amount provided: (1) The conditional power (CP) at interim is ≥ 50% and (2) there can be no decision to decrease the SS (stop the trial early). In this paper we verify this result for the case of a two-sample experiment with proportional SS in the treatment groups and an arbitrary common variance. Numerous authors have presented the formula for the CP at interim for a two-sample test with equal SS in the treatment groups and an arbitrary common variance, for both the one- and two-sided hypothesis tests. In this paper we derive the corresponding formula for the case of unequal, but proportional SS in the treatment groups for both one-sided superiority and two-sided hypothesis tests. Finally, we present an SAS macro for doing this calculation and provide a worked out hypothetical example. In discussion we note that this type of trial design trades the ability to stop early (for lack of efficacy) for the elimination of the Type I error penalty. The loss of early stopping requires that such a design employs a data monitoring committee, blinding of the sponsor to the interim calculations, and pre-planning of how much and under what conditions to increase the SS and that this all be formally written into an interim analysis plan before the start of the study.

摘要

对于方差已知为σ² =1的单样本实验,研究表明在中期分析时,只要满足以下条件,样本量(SS)可以任意增加:(1)中期的条件检验效能(CP)≥ 50%;(2)不能做出减少样本量(提前终止试验)的决定。在本文中,我们针对治疗组样本量成比例且方差任意相同的两样本实验验证了这一结果。许多作者已经给出了治疗组样本量相等且方差任意相同的两样本检验中期CP的公式,适用于单侧和双侧假设检验。在本文中,我们推导了治疗组样本量不等但成比例的单侧优效性和双侧假设检验情况下的相应公式。最后,我们给出了一个用于此计算的SAS宏,并提供了一个计算好的假设示例。在讨论中我们指出,这种类型的试验设计用消除I型错误惩罚来换取提前终止(因缺乏疗效)的能力。失去提前终止的能力要求这种设计采用数据监测委员会,使申办者对中期计算保持盲态,并且预先规划增加样本量的幅度和条件,并且这一切都要在研究开始前正式写入中期分析计划。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验